General Atlantic, L.P.
About General Atlantic, L.P.’s 13F portfolio
General Atlantic, L.P. is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , General Atlantic, L.P. reported $2.9B across 12 US-listed positions (). Its largest position is LIFTOFF MOBILE (LFTO) at 21% of the reported book, and its ten biggest holdings make up 99% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: LFTO LIFTOFF MOBILE | — — | 21% | 25.3M | $608.1M |
| 2 | NASDAQ: DLO DLOCAL | $12.89 +3.45% | 21% | 46.7M | $606.3M |
| 3 | NASDAQ: CHYM CHIME | $32.22 −2.27% | 15% | 21.3M | $435.4M |
| 4 | NASDAQ: ALKT ALKAMI | $13.13 −2.45% | 12% | 19.4M | $351.1M |
| 5 | NASDAQ: XP XP, INC | $14.06 −3.57% | 12% | 20.6M | $334.4M |
| 6 | NASDAQ: PHVS PHARVARIS | $31.55 −2.26% | 7.8% | 6.6M | $226.5M |
| 7 | NASDAQ: SPTX SEAPORT THERAPEUTICS | — — | 4.6% | 6.1M | $132.5M |
| 8 | NASDAQ: NRIX NURIX THERAPEUTICS | $14.10 −0.98% | 2.5% | 3.0M | $73.6M |
| 9 | NASDAQ: RVMD REVOLUTION MEDICINES | $159.82 −1.76% | 2.3% | 358K | $67.0M |
| 10 | NASDAQ: PBLS PARABILIS MEDICINES | — — | 1.4% | 1.5M | $42.1M |
| 11 | NYSE: RSKD RISKIFIED | $9.79 +1.03% | 0.9% | 5.3M | $26.8M |
| 12 | NYSE: GROV GROVE COLLABORATIVE | $0.81 −4.24% | 0.1% | 2.5M | $3.1M |
Showing the 12 largest positions reported in this 13F.
- Technology49%
- Healthcare13%
- Financial Services12%
- Consumer Defensive0.1%
- NewLFTOLIFTOFF MOBILE—$608.1M
- AddedALKTALKAMI+26.4%$351.1M
- NewSPTXSEAPORT THERAPEUTICS—$132.5M
- NewPBLSPARABILIS MEDICINES—$42.1M
- ReducedPHVSPHARVARIS−18.4%$226.5M
- ReducedNRIXNURIX THERAPEUTICS−26.1%$73.6M
- ReducedRVMDREVOLUTION MEDICINES−49.4%$67.0M
- SoldCNTACENTESSA PHARMACEUTICALS−100%—
- SoldEWCZEUROPEAN WAX CENTER−100%—
- SoldBULLWEBULL−100%—
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | DLO dLocal Ltd | 13D | 28.3% · 2 classes | 46.7M | Filed 09 SEP 2025 |
| 2 | ALKT ALKAMI TECHNOLOGY, INC. | 13D | 18.1% · 2 classes | 19.4M | Filed 15 MAY 2026 |
| 3 | LFTO Liftoff Mobile, Inc. | 13D | 15.0% | 25.3M | Filed 12 JUN 2026 |
| 4 | SPTX Seaport Therapeutics, Inc. | 13D | 11.5% | 6.1M | Filed 11 MAY 2026 |
| 5 | RSKD RISKIFIED LTD. | 13G | 9.5% | 10.6M | Filed 13 NOV 2026 |
| 6 | — Akero Therapeutics, Inc. | 13G | 8.4% | 6.8M | Filed 15 MAY 2025 |
| 7 | CYCN Korsana Biosciences, Inc. | 13G | 6.8% | 3.2M | Filed 18 SEP 2026 |
| 8 | ALHC Alignment Healthcare, Inc. | 13G | 6.6% | 13.2M | Filed 17 FEB 2026 |
| 9 | CHYM Chime Financial, Inc. | 13G | 5.6% | 19.2M | Filed 10 NOV 2025 |
| 10 | XP XP Inc. | 13D | 5.4% | 22.8M | Filed 04 DEC 2025 |
Showing all 10 disclosed stakes. 2 last disclosed over a year ago (the holder may since have dropped below 5%).
Reading General Atlantic, L.P.’s 13F portfolio
General Atlantic, L.P.’s $2.9B 13F book is spread across 12 reported positions and is highly concentrated — its ten largest positions alone are 99% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are LFTO, DLO, CHYM, ALKT and XP, led by LIFTOFF MOBILE (LFTO) at 21% of the portfolio. The heaviest sector exposure is Technology (49%), then Healthcare (13%).
What General Atlantic, L.P. changed last quarter
Between 2026-03-31 and Q2 2026, General Atlantic, L.P. was a net seller: it opened 3 new positions and added to 1 more, while trimming 3 and closing 3 outright. Against a 12-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was LIFTOFF MOBILE (LFTO), and its biggest reduction was PHARVARIS (PHVS).
What a 13F does and doesn’t reveal
A 13F captures only General Atlantic, L.P.’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names General Atlantic, L.P. is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. General Atlantic, L.P.'s profile on this page is built directly from those filings.
How current is the 13F data on General Atlantic, L.P.'s page?
It reflects General Atlantic, L.P.'s most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When General Atlantic, L.P. files its next quarterly report, this page refreshes automatically.
Can I see General Atlantic, L.P.'s complete list of holdings?
This page highlights General Atlantic, L.P.'s largest positions rather than all 12 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under General Atlantic, L.P.'s filings.
Does a 13F show everything General Atlantic, L.P. owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of General Atlantic, L.P.'s book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why General Atlantic, L.P. made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

